RESPIRATORY PANEL BY PCR (25)^

The RESPIRATORY PANEL BY PCR (25)^ is a multiplex molecular test that detects the genetic material of 25 common respiratory pathogens from a single nasopharyngeal or oropharyngeal swab. Using real-time PCR technology, the panel identifies specific viruses and bacteria to help distinguish the cause of respiratory symptoms quickly and accurately, enabling targeted treatment and appropriate infection-control measures.

This test is ideal for people with acute respiratory symptoms, high-risk patients (elderly, young children, immunocompromised, or those with chronic lung disease), and for clinicians managing outbreaks or triaging care. Samples are collected at home anywhere in Dubai by trained technicians, and results are typically reported to your treating physician and delivered via a secure patient portal within approximately 24–48 hours; consult your clinician for interpretation because PCR detects nucleic acid and may not always indicate active infection.

• SARS-CoV-2 (COVID-19)
• Influenza A
• Influenza A (H1N1)pdm09
• Influenza B
• Respiratory syncytial virus (RSV) A/B
• Human metapneumovirus
• Parainfluenza virus 1
• Parainfluenza virus 2
• Parainfluenza virus 3
• Parainfluenza virus 4
• Adenovirus
• Rhinovirus/Enterovirus
• Human coronavirus 229E
• Human coronavirus NL63
• Human coronavirus OC43
• Human coronavirus HKU1
• Mycoplasma pneumoniae
• Chlamydophila pneumoniae
• Bordetella pertussis
• Bordetella parapertussis
• Haemophilus influenzae
• Streptococcus pneumoniae
• Legionella pneumophila
• Moraxella catarrhalis
• Human bocavirus

• Onset of acute respiratory symptoms (fever, cough, sore throat, shortness of breath)
• Worsening or persistent symptoms despite initial treatment
• High-risk patients or those with chronic respiratory conditions
• Suspected community or household outbreak requiring pathogen identification
• Pre-hospital triage for admission decisions or infection-control planning

• Comprehensive detection of 25 viral and bacterial respiratory pathogens
• Rapid, accurate results to guide targeted treatment and reduce unnecessary antibiotics
• Convenient Dubai home sample collection by trained personnel
• Supports clinical decision-making, infection control, and public-health reporting
• Electronic delivery of results to your physician and secure patient portal

• Nasopharyngeal and/or oropharyngeal swab collected at home by a trained technician
• Sample ideally taken within the first 7 days of symptom onset for highest sensitivity
• Available for adults and children; please inform team of any nasal bleeding disorders or recent nasal surgery
• Valid Emirates ID and contact details required at time of booking; please remain isolated until results are received